Clinical utility of fluorescence in situ hybridization-based diagnosis of BCR-ABL1 like (Philadelphia chromosome like) B-acute lymphoblastic leukemia

Theodora Anagnostou, Ryan A. Knudson, Kathryn E. Pearce, Reid G. Meyer, Beth A. Pitel, Jess F. Peterson, Linda B. Baughn, Kaaren K. Reichard, Rhett P. Ketterling, Sara M. Kloft-Nelson, Darlene L. Knutson, Shakila P. Khan, Naseema Gangat, Mark R. Litzow, William J. Hogan, Alexandra Wolanskyj, Aref Al-Kali, Kebede H. Begna, Michelle Elliott, Animesh PardananiJames Foran, Mithun Shah, Ayalew Tefferi, Hassan Alkhateeb, Kevin Carl Halling, Vilmarie Rodriguez, Patricia T. Greipp, Mrinal M. Patnaik

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)E68-E72
JournalAmerican journal of hematology
Volume95
Issue number3
DOIs
StatePublished - Mar 1 2020

ASJC Scopus subject areas

  • Hematology

Cite this

Anagnostou, T., Knudson, R. A., Pearce, K. E., Meyer, R. G., Pitel, B. A., Peterson, J. F., Baughn, L. B., Reichard, K. K., Ketterling, R. P., Kloft-Nelson, S. M., Knutson, D. L., Khan, S. P., Gangat, N., Litzow, M. R., Hogan, W. J., Wolanskyj, A., Al-Kali, A., Begna, K. H., Elliott, M., ... Patnaik, M. M. (2020). Clinical utility of fluorescence in situ hybridization-based diagnosis of BCR-ABL1 like (Philadelphia chromosome like) B-acute lymphoblastic leukemia. American journal of hematology, 95(3), E68-E72. https://doi.org/10.1002/ajh.25729